Pre-Market Earnings Report for April 1, 2014 : TTNP, ULUR

By
A A A

The following companies are expected to report earnings prior to market open on 04/01/2014. Visit our Earnings Calendar for a full list of expected earnings releases.

Titan Pharmaceuticals, Inc. ( TTNP ) is reporting for the quarter ending December 31, 2013. The biomedical (gene) company's consensus earnings per share forecast from the 1 analyst that follows the stock is $0.00. This value represents a no change for the same quarter last year. Zacks Investment Research reports that the 2013 Price to Earnings ratio for TTNP is 5.58 vs. an industry ratio of -6.90, implying that they will have a higher earnings growth than their competitors in the same industry.

Uluru Inc. ( ULUR ) is reporting for the quarter ending December 31, 2013. The drug company's consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.04. This value represents a 60.00% increase compared to the same quarter last year. In the past year ULUR and beat the expectations the other quarter. Zacks Investment Research reports that the 2013 Price to Earnings ratio for ULUR is -7.90 vs. an industry ratio of 11.10.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , Earnings

Referenced Stocks: TTNP , ULUR

NASDAQ.com News

NASDAQ.com News

More from NASDAQ.com News:

Related Videos

Stocks

Referenced

Most Active by Volume

113,590,482
  • $14.98 ▼ 1.77%
57,689,941
  • $94.67 ▼ 0.37%
51,501,990
  • $3.31 ▼ 2.07%
46,645,770
  • $96.13 ▲ 0.55%
42,212,567
  • $72.36 ▼ 0.40%
39,428,076
  • $25.35 ▲ 0.80%
36,799,747
    $37 unch
36,459,390
  • $44.13 ▼ 2.35%
As of 8/1/2014, 04:03 PM